Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05749250 · ClinicalTrials.gov registry record · NA
Ultrasound Cavitation Therapy for CLI
A NA study, sponsored by University of Virginia.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT05749250 is a NA study that is actively recruiting participants, run by University of Virginia. The registered enrollment target is 30 participants.
The verdict
NCT05749250, a NA study, is actively recruiting participants, sponsored by University of Virginia.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
In this study, we will explore how ultrasound exposure of ultrasound contrast agents, which produces beneficial shear-mediated bioeffects, can be used to treat patients with severe non-healing ulcers secondary to peripheral arterial disease (PAD). The primary outcome measure is whether ultrasound exposure to microbubble contrast agents in the inflow artery and at the wound site can accelerate wound healing. A secondary outcome measure is whether cavitation-related changes occur in tissue perfusion in the treated limb and wound measured by ultrasound perfusion imaging and skin flow.
Interventions
- DEVICE Acoustic cavitation of ultrasound enhancing agents
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-01-01 |
| Est. Completion | 2025-06-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05749250
The ClinicalTrials.gov registry entry for NCT05749250 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Acoustic cavitation of ultrasound enhancing agents is the first listed.
NCT05749250 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05749250 about?
NCT05749250 is a clinical study titled "Ultrasound Cavitation Therapy for CLI". In this study, we will explore how ultrasound exposure of ultrasound contrast agents, which produces beneficial shear-mediated bioeffects, can be used to treat patients with severe non-healing ulcers secondary to peripheral arterial disease (PAD). The primary outcome measure is whether ultrasound ex...
What is the current status of trial NCT05749250?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2023-01-01. Estimated completion is 2025-06-28.
What interventions are being tested in trial NCT05749250?
The interventions under investigation include: Acoustic cavitation of ultrasound enhancing agents (DEVICE).
Who is sponsoring clinical trial NCT05749250?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.